The Eli Lilly and Company will acquire Adverum Biotechnologies, according to a joint press release issued by the 2 companies.
Learn more about whether AbbVie Inc. or Avidity Biosciences, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback